{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:57:28Z","timestamp":1793735848868,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prior studies suggested that antidepressant use is associated with an increased risk of dementia compared to no use, which is subject to confounding by indication. We aimed to compare the dementia risk among older adults with depression receiving first-line antidepressants (i.e., SSRI\/SNRI) versus psychotherapy, which is also considered the first-line therapy for depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study was conducted using the US Medical Expenditure Panel Survey from 2010 to 2019. We included adults aged\u2009\u2265\u200950 years diagnosed with depression who initiated SSRI\/SNRI or psychotherapy. We excluded patients with a dementia diagnosis before the first record of SSRI\/SNRI use or psychotherapy. The exposure was the patient\u2019s receipt of SSRI\/SNRI (identified from self-report questionnaires) or psychotherapy (identified from the Outpatient Visits or Office-Based Medical Provider Visits files). The outcome was a new diagnosis of dementia within 2 years (i.e., survey panel period) identified using ICD-9\/ICD-10 codes from the Medical Conditions file. Using a multivariable logistic regression model, we reported adjusted odds ratios (aORs) with 95% confidence intervals (CIs). We also conducted subgroup analyses by patient sex, age group, race\/ethnicity, severity of depression, combined use of other non-SSRI\/SNRI antidepressants, and presence of underlying cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 2,710 eligible patients (mean age\u2009=\u200961\u2009\u00b1\u20098, female\u2009=\u200969%, White\u2009=\u200984%), 89% used SSRIs\/SNRIs, and 11% received psychotherapy. The SSRI\/SNRI users had a higher crude incidence of dementia than the psychotherapy group (16.4% vs. 11.8%), with an aOR of 1.36 (95% CI\u2009=\u20091.06\u20131.74). Subgroup analyses yielded similar findings as the main analyses, except no significant association for patients who were aged\u2009&lt;\u200965 years (1.23, 95% CI\u2009=\u20090.93\u20131.62), male (1.34, 95% CI\u2009=\u20090.95\u20131.90), Black (0.76, 95% CI\u2009=\u20090.48\u20131.19), had a higher PHQ-2 (1.39, 95% CI\u2009=\u20090.90\u20132.15), and had underlying cognitive impairment (1.06, 95% CI\u2009=\u20090.80\u20131.42).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggested that older adults with depression receiving SSRIs\/SNRIs were associated with an increased dementia risk compared to those receiving psychotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-023-04475-z","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T13:02:15Z","timestamp":1702040535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Grace Hsin-Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsuan","family":"Lo-Ciganic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"3","key":"4475_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"A As","year":"2019","unstructured":"As A. 2019 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s and dementia. 2019;15(3):321\u201387.","journal-title":"Alzheimer\u2019s and dementia"},{"key":"4475_CR2","doi-asserted-by":"crossref","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75:336\u201346.","DOI":"10.1001\/jamapsychiatry.2017.4602"},{"key":"4475_CR3","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington, 2020. Available from http:\/\/vizhub.healthdata.org\/gbd-compare. (Accessed [Apr 8, 2022])."},{"issue":"5","key":"4475_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/archgenpsychiatry.2011.1481","volume":"69","author":"DE Barnes","year":"2012","unstructured":"Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of Dementia: differential effects for Alzheimer Disease and vascular Dementia. Arch Gen Psychiatry. 2012;69(5):493\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"4475_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-0839-1","volume":"10","author":"FS Dafsari","year":"2020","unstructured":"Dafsari FS, Jessen F. Depression\u2014an underrecognized target for prevention of Dementia in Alzheimer\u2019s Disease. Transl Psychiatry. 2020;10(1):1\u201313.","journal-title":"Transl Psychiatry"},{"key":"4475_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01067","volume":"10","author":"T Cassano","year":"2019","unstructured":"Cassano T, Calcagnini S, Carbone A, Bukke VN, Orkisz S, Villani R, et al. Pharmacological treatment of depression in Alzheimer\u2019s Disease: a challenging task. Front Pharmacol. 2019;10: 1067.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4475_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cpr.2007.04.004","volume":"28","author":"NJ Wolf","year":"2008","unstructured":"Wolf NJ, Hopko DR. Psychosocial and pharmacological interventions for depressed adults in primary care: a critical review. Clin Psychol Rev. 2008;28(1):131\u201361.","journal-title":"Clin Psychol Rev"},{"key":"4475_CR8","volume-title":"In: Corsini RJ, editor","author":"D Wedding","year":"2013","unstructured":"Wedding D. In: Corsini RJ, editor. Current psychotherapies: Cengage Learning; 2013."},{"key":"4475_CR9","doi-asserted-by":"publisher","unstructured":"Andrade C, Rao NS. How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry. 2010;52:378\u201386. https:\/\/doi.org\/10.4103\/0019-5545.74318.","DOI":"10.4103\/0019-5545.74318"},{"key":"4475_CR10","unstructured":"Barrisford GW, Steele GS. Acute urinary retention. In: Post T, ed. UpToDate. Waltham, MA: UpToDate; 2018. www.uptodate.com\/contents\/acute-urinary-retention External link. Updated September 29, 2021. Accessed 11 June 2022."},{"key":"4475_CR11","doi-asserted-by":"publisher","unstructured":"Wang Y-C, Tai P-A, Poly TN, Islam MM, Yang H-C, Wu C-C et al.\u00a0Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies\". Behav Neurol. 2018;2018:8. Article ID 5315098. https:\/\/doi.org\/10.1155\/2018\/5315098.","DOI":"10.1155\/2018\/5315098"},{"issue":"11","key":"4475_CR12","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jagp.2019.05.019","volume":"27","author":"A Kodesh","year":"2019","unstructured":"Kodesh A, Sandin S, Reichenberg A, Rotstein A, Pedersen NL, Ericsson M, et al. Exposure to antidepressant medication and the risk of incident Dementia. Am J Geriatric Psychiatry. 2019;27(11):1177\u201388.","journal-title":"Am J Geriatric Psychiatry"},{"issue":"6103","key":"4475_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.1222941","volume":"338","author":"AJ Eisch","year":"2012","unstructured":"Eisch AJ, Petrik D. Depression and hippocampal neurogenesis: a road to remission? Science. 2012;338(6103):72\u20135.","journal-title":"Science"},{"issue":"4","key":"4475_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5414\/CP202754","volume":"55","author":"L Jacob","year":"2017","unstructured":"Jacob L, Bohlken J, Kostev K. Risk of Dementia in German patients treated with antidepressants in general or psychiatric practices. Int J Clin Pharmacol Ther. 2017;55(4):322\u20138.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"7","key":"4475_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jamda.2019.03.037","volume":"20","author":"TM Liew","year":"2019","unstructured":"Liew TM. Antidepressant and risk of Dementia: confounding by indication. J Am Med Dir Assoc. 2019;20(7):920\u20132.","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"4475_CR16","first-page":"CD003944","volume":"8","author":"R Dudas","year":"2018","unstructured":"Dudas R, Malouf R, McCleery J, Dening T. Antidepressants for treating depression in Dementia. Cochrane Database Syst Rev. 2018;8(8):CD003944\u2013CD.","journal-title":"Cochrane Database Syst Rev"},{"key":"4475_CR17","unstructured":"Agency for Health Research and Quality. Medical Expenditure Panel Survey Download Data Files. Accessed 11 October 2022. https:\/\/www.meps.ahrq.gov\/mepsweb\/data_stats\/download_data_files.jsp [."},{"issue":"1","key":"4475_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-021-03501-x","volume":"21","author":"APB Pena-Gralle","year":"2021","unstructured":"Pena-Gralle APB, Talbot D, Trudel X, Aub\u00e9 K, Lesage A, Lauzier S, et al. Validation of case definitions of depression derived from administrative data against the CIDI-SF as reference standard: results from the PROspective Qu\u00e9bec (PROQ) study. BMC Psychiatry. 2021;21(1):1\u20139.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"4475_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cger.2013.07.009","volume":"29","author":"NL Campbell","year":"2013","unstructured":"Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA. Risk factors for the progression of mild cognitive impairment to Dementia. Clin Geriatr Med. 2013;29(4):873\u201393.","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"4475_CR20","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/S2468-2667(20)30185-7","volume":"5","author":"L Jia","year":"2020","unstructured":"Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, et al. Prevalence, risk factors, and management of Dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. The Lancet Public Health. 2020;5(12):e661\u201371.","journal-title":"The Lancet Public Health"},{"issue":"6","key":"4475_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","volume":"11","author":"M Baumgart","year":"2015","unstructured":"Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and Dementia: a population-based perspective. Alzheimer\u2019s Dement. 2015;11(6):718\u201326.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"4475_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1370\/afm.1139","volume":"8","author":"B Arroll","year":"2010","unstructured":"Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. The Annals of Family Medicine. 2010;8(4):348\u201353.","journal-title":"The Annals of Family Medicine"},{"key":"4475_CR23","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JA Sterne","year":"2009","unstructured":"Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.","journal-title":"BMJ"},{"issue":"7","key":"4475_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/aje\/kwq198","volume":"172","author":"T St\u00fcrmer","year":"2010","unstructured":"St\u00fcrmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2013a simulation study. Am J Epidemiol. 2010;172(7):843\u201354.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"4475_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12874-016-0253-9","volume":"16","author":"A Pezzi","year":"2016","unstructured":"Pezzi A, Cavo M, Biggeri A, Zamagni E, Nanni O. Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for Multiple Myeloma. BMC Med Res Methodol. 2016;16(1):150.","journal-title":"BMC Med Res Methodol"},{"issue":"30","key":"4475_CR26","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1002\/sim.7084","volume":"35","author":"PC Austin","year":"2016","unstructured":"Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med. 2016;35(30):5642\u201355.","journal-title":"Stat Med"},{"key":"4475_CR27","unstructured":"Using Statistical Software Packages to Produce Estimates from MEPS Data Files. Accessed through: https:\/\/meps.ahrq.gov\/survey_comp\/hc_samplecodes_se.shtml [Sep 29, 2023]."},{"issue":"1","key":"4475_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/1475-6773.12090","volume":"49","author":"EH DuGoff","year":"2014","unstructured":"DuGoff EH, Schuler M, Stuart EA. Generalizing observational study results: applying propensity score methods to complex surveys. Health Serv Res. 2014;49(1):284\u2013303.","journal-title":"Health Serv Res"},{"issue":"1","key":"4475_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/0193841X20938497","volume":"44","author":"N Dong","year":"2020","unstructured":"Dong N, Stuart EA, Lenis D, Quynh Nguyen T. Using propensity score analysis of survey data to estimate population average treatment effects: a case study comparing different methods. Eval Rev. 2020;44(1):84\u2013108.","journal-title":"Eval Rev"},{"issue":"7","key":"4475_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/aje\/kwq439","volume":"173","author":"MJ Funk","year":"2011","unstructured":"Funk MJ, Westreich D, Wiesen C, St\u00fcrmer T, Brookhart MA, Davidian M. Doubly robust estimation of causal effects. Am J Epidemiol. 2011;173(7):761\u20137.","journal-title":"Am J Epidemiol"},{"issue":"13","key":"4475_CR31","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jama.2019.1954","volume":"321","author":"EC Norton","year":"2019","unstructured":"Norton EC, Dowd BE, Maciejewski ML. Marginal effects\u2014quantifying the effect of changes in risk factors in logistic regression models. JAMA. 2019;321(13):1304\u20135.","journal-title":"JAMA"},{"issue":"1","key":"4475_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4088\/JCP.14m09580","volume":"77","author":"CW-S Lee","year":"2016","unstructured":"Lee CW-S, Lin C-L, Sung F-C, Liang J-A, Kao C-H. Antidepressant treatment and risk of Dementia: a population-based, retrospective case-control study. J Clin Psychiatry. 2016;77(1):961.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"4475_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035147","volume":"10","author":"G Peakman","year":"2020","unstructured":"Peakman G, Karunatilake N, Seynaeve M, Perera G, Aarsland D, Stewart R, et al. Clinical factors associated with progression to Dementia in people with late-life depression: a cohort study of patients in secondary care. BMJ Open. 2020;10(5): e035147.","journal-title":"BMJ Open"},{"issue":"8","key":"4475_CR34","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1017\/S1041610211002778","volume":"24","author":"JS Goveas","year":"2012","unstructured":"Goveas JS, Hogan PE, Kotchen JM, Smoller JW, Denburg NL, Manson JE, et al. Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the women\u2019s Health Initiative Memory Study. Int Psychogeriatr. 2012;24(8):1252\u201364.","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"4475_CR35","first-page":"357","volume":"26","author":"T Si","year":"2014","unstructured":"Si T, Wang P. When is antidepressant polypharmacy appropriate in the treatment of depression? Shanghai Arch Psychiatry. 2014;26(6):357\u20139.","journal-title":"Shanghai Arch Psychiatry"},{"issue":"6","key":"4475_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","volume":"7","author":"AL Byers","year":"2011","unstructured":"Byers AL, Yaffe K. Depression and risk of developing Dementia. Nat Rev Neurol. 2011;7(6):323\u201331.","journal-title":"Nat Rev Neurol"},{"key":"4475_CR37","doi-asserted-by":"publisher","unstructured":"Remmert JE, Guzman G, Mavandadi S, Oslin D.\u00a0Racial Disparities in Prescription of Antidepressants Among U.S. Veterans Referred to Behavioral Health Care. Psychiatr Serv. 2022;73:984\u201390. https:\/\/doi.org\/10.1176\/appi.ps.202100237.","DOI":"10.1176\/appi.ps.202100237"},{"issue":"2","key":"4475_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10654-016-0144-8","volume":"31","author":"J Goudsmit","year":"2016","unstructured":"Goudsmit J. The incubation period of Alzheimer\u2019s Disease and the timing of tau versus amyloid misfolding and spreading within the brain. Eur J Epidemiol. 2016;31(2):99\u2013105.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"4475_CR39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S2215-0366(16)00097-3","volume":"3","author":"SS Mirza","year":"2016","unstructured":"Mirza SS, Wolters FJ, Swanson SA, Koudstaal PJ, Hofman A, Tiemeier H, et al. 10-year trajectories of depressive symptoms and risk of Dementia: a population-based study. The Lancet Psychiatry. 2016;3(7):628\u201335.","journal-title":"The Lancet Psychiatry"},{"issue":"5","key":"4475_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/pds.4197","volume":"26","author":"C Renoux","year":"2017","unstructured":"Renoux C, Dell\u2019Aniello S, Brenner B, Suissa S. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism. Pharmacoepidemiol Drug Saf. 2017;26(5):554\u201360.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-04475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-023-04475-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-04475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T13:04:56Z","timestamp":1702040696000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-023-04475-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1186\/s12877-023-04475-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3266805\/v1","asserted-by":"object"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study used Medical Expenditure Panel Survey (MEPS) data, which is reviewed and approved by the Westat Institutional Review Board (IRB) annually and is established under a multi-project assurance (MPA M-1531) granted by the Office for Protection from Research Risks. After carefully removing individual\u2019s identifiable information, an annual series of Public Use Files of de-identified MEPS data are made publicly available to researchers (\n                      \n                      ). Due to the nature of de-identification and public availability of the MEPS data, the University of Florida IRB determined the study exempt and did not require informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"825"}}